14. Net Loss Per Share Attributable to Common Stockholders

As described in Note 12, the Pre-Funded Warrants to purchase up to an aggregate of 800,000 shares of the Company's common stock at a purchase price of $9.9999 per Pre-Funded Warrant were classified as a component of equity in the Company's condensed consolidated balance sheets upon entering the 2025 Securities Purchase Agreement because they were freestanding financial instruments that were immediately exercisable, did not embody an obligation for the Company to repurchase its own shares, and entitled the holder to receive a fixed number of shares of common stock upon exercise. All of the shares underlying the Pre-Funded Warrants were included in the weighted-average number of shares of common stock used to calculate basic and diluted net loss per common share upon entering the 2025 Securities Purchase Agreement because the shares may have been issued for little or no consideration, were fully vested, and were exercisable after the original issuance date of the Pre-Funded Warrants. On April 13, 2026, all of the Pre-Funded Warrants were exercised on a cashless basis, resulting in the issuance of 799,987 shares of the Company’s common stock. As of June 30, 2026, no Pre-Funded Warrants remained outstanding.